Skip to main content

Table 3 Summary of recommendations

From: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us